Company Completes Accelerated Share Repurchase Program
New Three-Year, $750 Million Authorization Reflects Continued Confidence in Company’s Fundamental Strength and Long-Term Strategic Outlook
Adtalem Global Education Inc. (NYSE: ATGE), America’s largest healthcare educator, today announced the completion of its $150 million share repurchase program, under which the Company repurchased approximately 1.6 million shares, and a new $750 million share repurchase authorization approved by the Board of Directors through December 2028. The new three-year authorization underscores management and the Board’s conviction in Adtalem’s strategic direction, strong financial position, and ability to generate substantial cash flow while continuing to invest in growth initiatives.
“Our operational execution continues to generate strong cash flow, giving us the flexibility to invest in significant growth opportunities while returning capital to shareholders in a tax-efficient manner,” said Steve Beard, chairman and chief executive officer, Adtalem Global Education. “This new repurchase authorization reflects our disciplined, return-on-investment approach to capital allocation. The demand for what we do—preparing the healthcare workforce our country needs—continues to accelerate, and we have the financial strength to both capitalize on that opportunity and reward our shareholders.”
Since February 2022, Adtalem has returned $913 million to shareholders by repurchasing 17.2 million shares at an average price of $52.95 which represents a 30% reduction in shares outstanding against base shares outstanding as of Feb. 1, 2022. The company has 34.9 million shares of common stock outstanding as of Dec. 10, 2025. The Company has also taken significant steps to strengthen its balance sheet, reducing its debt by $1.1 billion since closing the Walden University acquisition on Aug. 31, 2021 to $508.4 million as of Oct. 31, 2025.
Repurchases under the new authorization can be made from time to time using a variety of methods, which may include open market purchases, privately negotiated transactions or otherwise, all in accordance with the rules of the Securities and Exchange Commission and other applicable legal requirements. The specific timing, price and size of purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations.
First quarter fiscal year 2026 results and financial reconciliations can be found on the Adtalem investor relations website at investors.adtalem.com.
Adtalem will host an Investor Day where it plans to provide a comprehensive strategic and operational update, scheduled for February 24, 2026.
Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!
